The Independent Role of Elevated Serum Calcium on Bone Metabolism
Elevated calcium levels may lead to suboptimal growth of bone, according to the study’s findings.
Endocrinology Information Center
Treatment Choice for T2DM in Obese Teens Tied to Later Kidney Disease Risk
Odds of diabetic kidney disease higher in obese teens receiving medical therapy vs bariatric surgery for T2DM.
Pediatric Obesity Treatment Not Associated With Increased Risk for Anxiety, Depression
Researchers used patient databases to investigate the association between obesity treatment interventions with a dietary component and the change in symptoms of depression and anxiety in pediatric patients who were overweight or obese.
Weight-Loss Counseling With Group Visits Improves HbA1c
Weight management/group medical visit arm had lower diabetes medication use, greater weight loss.
Would Warning Labels on Sugar-Sweetened Beverages Affect Obesity in the US?
A recent study used a simulation model to project the possible effects of including warning labels on sugar-sweetened beverages on the body weight and dietary behaviors of US adults.
Diagnosis of Treatment-Resistant Hypertension Predicts Mortality Outcomes in T2D
For patients with type 2 diabetes, apparent treatment-resistant hypertension increases risk for cardiovascular events and mortality.
In T2DM Patients, Anemia Tied to Diabetic Retinopathy
In patients with type 2 diabetes mellitus, anemia is associated with the development of diabetic retinopathy.
AAP Recommends Expanding Access to Bariatric Surgery for Adolescents
The American Academy of Pediatrics (AAP) announced a set of practice- and system-level recommendations in a position statement presented at the 2019 AAP National Conference & Exhibition.
Treatment Approach to Adolescent Obesity: A Clinical Update
Treatment for adolescent obesity should be guided by patient age, pubertal status, severity of obesity, psychosocial factors, and comorbidities.
Weight Loss Maintenance Important for Cardiometabolic Risk Control in T2D
A larger percentage of weight loss regained after an intensive lifestyle intervention was positively associated with certain cardiometabolic risk factors in type 2 diabetes.
Nearly 5 Million Youth Are Obese in the United States
Obesity rate has held steady in recent years.
Too Much, Too Little Weight Gain May Harm Twin Pregnancies
Study informs guidance for ranges of safe, unsafe weight gain in twin pregnancies.
Patients With T2DM Who Have Flu More Likely to Be Hospitalized
Mortality risk for flu-related hospitalizations lower for those with vs without type 2 diabetes.
Recommendations for Secondary Fracture Prevention in Elderly Patients
The American Society for Bone and Mineral Research developed 13 clinical recommendations (7 primary and 6 secondary) to address the undertreatment of osteoporosis-related fractures and prevent secondary fracture among persons aged ≥65 years with hip or vertebral fractures.
Fecal Microbiota Transplant in the Treatment of Obesity
The human gut microbiota has been identified as a metabolic organ having a significant effect on host metabolism.
Probiotics May Improve BMI in Children With Obesity
Receiving 12 weeks of probiotic supplement can improve body mass index as well as components of the inflammatory and glycolipid metabolism in obese children.
Type 2 Diabetes Prevalent Among People Living With HIV
Approximately 1 in 5 people with HIV also has prevalent DM, and control of hemoglobin A1c levels in these patients may have a beneficial effect on CD4 counts.
How Does Health Status Affect Insulin Use in Older Individuals With Type 2 Diabetes?
Among older individuals with type 2 diabetes, insulin use is least prevalent in those in good health, and discontinuation of insulin treatment is most likely in healthier patients.
Primary Care Use Aids Patients With Diabetes and Coexisting Psych Disorders
More primary care for patients with mental health, substance use disorders may affect diabetes severity.
Fezolinetant Reduces Frequency, Severity of Vasomotor Symptoms in Menopause
The neurokinin 3 receptor antagonist fezolinetant reduces the frequency and severity of vasomotor symptoms in menopause.
Want to read more?
Please login or register first to view this content.
